|
Aug 12
|
Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda
|
|
Aug 12
|
Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise
|
|
Aug 11
|
Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?
|
|
Aug 11
|
Take the Zacks Approach to Beat the Markets: Digi Power X, RF Industries & Starbucks in Focus
|
|
Aug 11
|
Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth
|
|
Aug 11
|
Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations
|
|
Aug 9
|
5 Dividend Stocks to Hold for the Next 5 Years
|
|
Aug 9
|
If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?
|
|
Aug 9
|
3 Stocks Retirees Should Absolutely Love
|
|
Aug 8
|
Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season
|
|
Aug 8
|
Sigmoidoscopes Market Insights, Competitive Landscape, and Forecast 2022-2024 & 2025-2032 | North America, Healthcare Advancements and Geriatric Populations Drive Growth
|
|
Aug 7
|
Genmab raises full-year outlook, shares rise
|
|
Aug 7
|
Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?
|
|
Aug 7
|
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
|
|
Aug 7
|
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical
|
|
Aug 7
|
Band-Aid maker Kenvue cuts annual sales forecast amid strategic review
|
|
Aug 6
|
Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029
|
|
Aug 6
|
HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View
|
|
Aug 6
|
Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio
|
|
Aug 6
|
Bayer Beats on Q2 Earnings and Sales, Raises '25 Adjusted Sales View
|